Mind Medicine (MNMD) announced the appointment of Brandi Roberts as its CFO, effective June 2. In her new role, Roberts will join MindMed’s executive leadership team where she will oversee all aspects of financial strategy, capital planning, accounting, investor relations and information technology. Most recently, she served as CFO and executive VP of Longboard Pharmaceuticals, where she helped lead the company through its IPO, multiple financings, and ultimately, its $2.6B acquisition by Lundbeck in 2024.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MNMD:
- Mind Medicine’s Strategic Advancements and Late-Stage Pipeline Progress Justify Buy Rating
- MindMed to Participate in 2025 RBC Healthcare Conference
- Mind Medicine’s Promising Pipeline and Robust Financial Health Drive Buy Rating
- MindMed’s Strategic Positioning and Financial Strength Underpin ‘Buy’ Rating
- MindMed Advances Phase 3 Trials for Brain Health